Company Filing History:
Years Active: 2006-2015
Title: Innovations of Aleksandr M Itkin in Pharmaceutical Chemistry
Introduction
Aleksandr M Itkin is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical chemistry. With a total of 6 patents to his name, Itkin has focused on developing methods for synthesizing important anthracycline compounds, which are crucial in cancer treatment.
Latest Patents
Among his latest patents, Itkin has developed a method for preparing 4-demethyldaunorubicin. This innovative process involves reacting daunorubicin or N-protected daunorubicin with soft Lewis acids to demethylate the 4-methoxy group. The resulting reaction mass is treated with an aqueous solution of a strong organic acid or a mineral acid, leading to the extraction of carminomycin as a base. Another significant patent is the synthesis of epirubicin from 13-dihydrodaunorubicine. This method includes several steps, such as acylation and the use of reducing agents, to produce the desired final compound.
Career Highlights
Itkin is currently associated with Solux Corporation, where he continues to innovate in the field of drug development. His work has been instrumental in advancing the synthesis of vital pharmaceutical compounds, contributing to improved treatment options for patients.
Collaborations
Throughout his career, Itkin has collaborated with esteemed colleagues, including Victor Matvienko and Alexander F Zabudkin. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Aleksandr M Itkin's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in cancer treatment and drug synthesis.